OBJECTIVES: To explore the full economic impact, on both patients and government, as a result of COPD in the working age population. METHODS: The economic impact of COPD due to medical treatment, impaired productivity and early retirement was assessed in a cross sectional cost analysis of the Dutch COPD population aged 45-64 years. The costing year was 2009 and input parameters were derived from both national data sources and the international COPD uncovered survey. RESULTS: While direct medical costs for COPD patients of working age were relatively low (€ 91 million), the amount of lost productivity (income) due to early retirement (€ 223 million) exceeded over two times their medical costs. In addition, costs for the government were considerable because of lost tax revenues (€ 77 million) and COPD related disability pensions paid (€ 180 million). Apart from lost productivity due to early retirement, costs due to impaired productivity for working COPD patients were € 63 million. CONCLUSIONS: The costs of COPD for both patients of working age as for the government were considerable, making this population a priority for prevention and intervention programs of healthcare providers, employers and government.
OBJECTIVES: To explore the full economic impact, on both patients and government, as a result of COPD in the working age population. METHODS: The economic impact of COPD due to medical treatment, impaired productivity and early retirement was assessed in a cross sectional cost analysis of the Dutch COPD population aged 45-64 years. The costing year was 2009 and input parameters were derived from both national data sources and the international COPD uncovered survey. RESULTS: While direct medical costs for COPDpatients of working age were relatively low (€ 91 million), the amount of lost productivity (income) due to early retirement (€ 223 million) exceeded over two times their medical costs. In addition, costs for the government were considerable because of lost tax revenues (€ 77 million) and COPD related disability pensions paid (€ 180 million). Apart from lost productivity due to early retirement, costs due to impaired productivity for working COPDpatients were € 63 million. CONCLUSIONS: The costs of COPD for both patients of working age as for the government were considerable, making this population a priority for prevention and intervention programs of healthcare providers, employers and government.
Authors: Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-01-18 Impact factor: 8.082
Authors: Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-04-03 Impact factor: 8.082
Authors: Job Fm van Boven; Eline Tommelein; Koen Boussery; Els Mehuys; Stefan Vegter; Guy Go Brusselle; Maureen Pmh Rutten-van Mölken; Maarten J Postma Journal: Respir Res Date: 2014-06-14
Authors: Job F M van Boven; Joost J van Raaij; Ruben van der Galiën; Maarten J Postma; Thys van der Molen; P N Richard Dekhuijzen; Stefan Vegter Journal: NPJ Prim Care Respir Med Date: 2014-10-02 Impact factor: 2.871
Authors: Miguel Román-Rodríguez; Marina Garcia Pardo; Lucia Gorreto López; Ana Uréndez Ruiz; Job F M van Boven Journal: NPJ Prim Care Respir Med Date: 2016-03-10 Impact factor: 2.871
Authors: Evalyne M Jansen; Susanne J van de Hei; Boudewijn J H Dierick; Huib A M Kerstjens; Janwillem W H Kocks; Job F M van Boven Journal: J Thorac Dis Date: 2021-06 Impact factor: 2.895
Authors: Job F M van Boven; Miguel Román-Rodríguez; Janwillem W H Kocks; Joan B Soriano; Maarten J Postma; Thys van der Molen Journal: NPJ Prim Care Respir Med Date: 2015-08-06 Impact factor: 2.871